FY25 consensus $4.69. Backs FY25 organic revenue growth of 2%-3% year-over-year, consensus $19.99B. EPS guidance includes ~85c of tariff impact.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on GEHC:
- Notable companies reporting before tomorrow’s open
- GE Hlthcare Tech Inc call volume above normal and directionally bullish
- Early notable gainers among liquid option names on April 25th
- Buy Rating for GE Healthcare Technologies Inc: Promising Outlook with Flyrcado’s Market Potential and Improved Valuation Dynamics
- China weighing exemption of some U.S. goods from tariffs, Bloomberg reports